- Bone marrow aspiration and biopsy may be necessary.
- Bone scan may be necessary.
- CT scan or MRI scan of the affected area
- MIBG scan may be necessary.
- Specialized blood and urine tests
- Surgical biopsy to confirm diagnosis
- Invasion of the tumor into surrounding areas (spread of the tumor)
- Complications of surgery, radiation, or chemotherapy
Ganglioneuroblastoma is an intermediate tumor arising from nerve tissue. An intermediate tumor is one that is between benign (slow-growing and unlikely to spread) and malignant (fast-growing, aggressive, and likely to spread).
Causes, incidence, and risk factors
This rare tumor has a yearly occurrence of less than 5 per 1,000,000 children.
Tumors of the nervous system vary in their degree of differentiation. The degree of differentiation determines how the tumors appear under the microscope and whether or not they are likely to spread.
Benign tumors are less likely to spread. Malignant tumors are aggressive, grow quickly, and often spread. A ganglioneuroma is a benign tumor, while a neuroblastoma (occurring in children more than a year old) is generally malignant.
A ganglioneuroblastoma may be localized to one area or it may be widespread, but it is usually less aggressive than a neuroblastoma. The cause is unknown.
Most commonly, a mass can be felt in the abdomen, but this condition may also occur in other parts of the body.
Signs and tests
Because these tumors are rare, they should be treated in a specialized center by experts who have experience with them.
Depending on the specific nature of the tumor, treatment can consist of surgery, and possibly chemotherapy and radiation therapy.
The prognosis depends on the extent of the tumor and whether or not some areas of the tumor contain the more aggressive cells of a neuroblastoma.
Calling your health care provider
Call your health care provider if you feel a mass or growth on your child's body. Make sure children receive routine examinations as part of their well child care.
Sovak MA, Aisner SC, Aisner J. Tumors of the pleura and mediastinum. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 77.
Kim S, Chung DH. Pediatric solid malignancies: neuroblastoma and Wilms' tumor. Surg Clin North Am. 2006;86(2):469-487.
Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am. 2008;55(1):97-120.
- Review date:
- March 2, 2010
- Reviewed by:
- David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc., and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.